Akers Biosciences
- In Vitro and In Vivo Diagnostic Substances
- Baltimore, Maryland
Compensation history
Top executives at Akers Biosciences received an average of $717K per person in annual compensation from 2011 to 2023.
Average pay of disclosed executives at Akers Biosciences
By year
Executives
We found ten executives who work or worked at Akers Biosciences.
Christopher Chapman
Akers Biosciences
Chief Medical Officer
Adam Kaplin
Akers Biosciences
Chief Scientific Officer
Ian Rhodes
Akers Biosciences
Chief Financial Officer
Paul Rivard
Akers Biosciences
Chief Legal Officer
Christopher Schreiber
Akers Biosciences
Chief Executive Officer
Howard Yeaton
Akers Biosciences
Chief Executive Officer
Raymond Akers
Akers Biosciences
Secretary
Thomas Nicolette
Akers Biosciences
Chief Executive Officer
News
Akers Biosciences Chief Medical Officer Christopher Chapman's 2023 pay jumps 1,002% to $2.9M
November 1, 2024
Akers Biosciences CSO Adam Kaplin's 2022 pay falls 93% to $354K
June 30, 2023
Akers Biosciences CSO Adam Kaplin's 2021 pay jumps 1,350% to $5.2M
October 26, 2022
Akers Biosciences CEO Christopher Schreiber's 2020 pay jumps 1,909% to $1.1M
November 22, 2021
About Akers Biosciences
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryIn Vitro and In Vivo Diagnostic Substances
- Address855 N. Wolfe Street, Suite 601, Baltimore, Maryland 21205
- Phone856-848-8698
- Fiscal year endDecember 31
- Former names
- MyMD Pharmaceuticals, Inc.Until June 30, 2024
- Akers Biosciences, Inc.Until April 15, 2021
- Akers Biosciences IncUntil April 10, 2017
Source: SEC filings on November 1, 2024, June 30, 2023, October 26, 2022, November 22, 2021, June 5, 2015, and October 17, 2014.